Trials / Sponsors / Elicio Therapeutics
Elicio Therapeutics
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, KRAS G12D | Phase 1 / Phase 2 | 2023-04-14 |
| Completed | A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumor Minimal Residual Disease, KRAS G12D, KRAS G12R | Phase 1 | 2021-10-04 |
| Available | Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma, KRAS G12D, KRAS G12V | — | — |